Pacific Edge slashes team on US 'uncertainty'

Pacific Edge slashes team on US 'uncertainty'
(Image: PEB)
Brent Melville
Pacific Edge has halved its sales team after uncertainty over its future in its core US market, with a pending decision on whether medicare contractor Novitas will cover US testing.  The cancer diagnostic company, dual listed on the New Zealand and Australian stock exchanges, slashed its commercial team from 34 to 17 as it restructured its operations after a 17.78% drop in test volumes for its Cxbladder product in its core US market for the December quarter.The Dunedin firm said it had processed 7,172 tests during the final three months of...

More Markets

Lower bond yields lift NZ sharemarket
Markets Market Close

Lower bond yields lift NZ sharemarket

Lower bond yields have helped drive the NZ sharemarket sharply higher at the close.

Jamie Gray 30 May 2025
Turbulent market slashes 2 Cheap Cars' profit
Markets

Turbulent market slashes 2 Cheap Cars' profit

New Zealand’s continued economic downturn, a sharp fall in immigration and consequent softer market demand has driven a 47% drop in profit for 2 Cheap Cars.The company reported total revenue of $81.9 million with 7675 cars sold in the year to March 31, down 6% compared to $86.7m...

Staff reporters 30 May 2025
Pacific Edge launches $20m capital raise
Markets

Pacific Edge launches $20m capital raise

The raise will help the medtech company continue operations for another year.

Staff reporters 30 May 2025
King Salmon slashes earnings guidance
Primary Sector

King Salmon slashes earnings guidance

Reduced harvests are needed to build up fish stocks.

Staff reporters 30 May 2025